Items where authors include "Van Bocxlaer, Katrien"

Article

Parkash, Vivak orcid.org/0000-0001-9701-5767, Ashwin, Helen, Dey, Shoumit orcid.org/0000-0003-2655-9921 et al. (12 more authors) (2024) Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis. Nature Medicine. ISSN 1078-8956

Alpizar-Sosa, Edubiel A, Zimbres, Flavia M, Mantilla, Brian S et al. (12 more authors) (2024) Evaluation of the Leishmania Inositol Phosphorylceramide Synthase as a Drug Target Using a Chemical and Genetic Approach. ACS Infectious Diseases. ISSN 2373-8227

Romero, Eder Lilia, Van Bocxlaer, Katrien and Formiga, Fabio Rocha (2024) When nanomedicines meet tropical diseases. Beilstein Journal of Nanotechnology. pp. 830-832. ISSN 2190-4286

Van Bocxlaer, Katrien, Dixon, Jodie, Platteeuw, Johannes J et al. (6 more authors) (2023) Efficacy of oleylphosphocholine in experimental cutaneous leishmaniasis. The Journal of antimicrobial chemotherapy. pp. 1723-1731. ISSN 1460-2091

Wijnant, Gert Jan, Dumetz, Franck, Dirkx, Laura et al. (4 more authors) (2022) Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis. Frontiers in Tropical Diseases. 837460. ISSN 2673-7515

Van Bocxlaer, Katrien, McArthur, Kerri-Nicola, Harris, Andy et al. (4 more authors) (2021) Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis. Pharmaceutics. 516. ISSN 1999-4923

Ashwin, Helen, Sadlova, Jovana, Vojtkova, Barbora et al. (14 more authors) (2021) Characterization of a new Leishmania major strain for use in a controlled human infection model. Nature Communications. 215. p. 215. ISSN 2041-1723

Van Bocxlaer, Katrien and Croft, Simon L (2021) Pharmacokinetics and pharmacodynamics in the treatment of cutaneous leishmaniasis - challenges and opportunities. RSC Medicinal Chemistry. pp. 472-482. ISSN 2632-8682

Kaye, Paul M orcid.org/0000-0002-8796-4755, Cruz, Israel, Picado, Albert et al. (2 more authors) (2020) Leishmaniasis immunopathology-impact on design and use of vaccines, diagnostics and drugs. Seminars in immunopathology. pp. 1-18. ISSN 1863-2300